P/E Ratio

The P/E ratio (price-to-earnings) compares a stock’s share price to its earnings per share; a P/E of 32.8x means investors pay $32.80 for every $1 of Cardinal Health’s annual earnings.

This is above the healthcare sector median of 27.0x, placing the stock in the 70th percentile among its peers—indicating a premium valuation relative to the typical sector company. The P/E trend data is not available, as the year-over-year and quarter-over-quarter changes are both listed as N/A, and no prior periods are provided for comparison. Because the current P/E sits well above the sector median but shows no trend direction to assess momentum, the valuation appears stretched without confirming whether it is expanding or contracting, which introduces uncertainty for investors. This elevated valuation level does not inherently signal a buying opportunity and, combined with the lack of trend data, suggests caution. The metric supports the overall NEUTRAL verdict by highlighting a pricey valuation that lacks a clear directional catalyst to justify a bullish or bearish stance.

Frequently Asked Questions

Closest Sector Peers